http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 10 Mar 2026 16:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Can-Fite+BioPharma+Ltd.+++For%3A+Mar+10/26139925.html si-local-file:///var/storage/secattach/20260310/26139925.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Can-Fite+BioPharma+Ltd.+++For%3A+Mar+10/26139925.html Tue, 10 Mar 2026 16:30:00 -0400 CANF CANF O.05892622 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Can-Fite+BioPharma+Ltd.+++For%3A+Mar+10/26139925.html si-local-file:///var/storage/secattach/20260310/26139925.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Can-Fite+BioPharma+Ltd.+++For%3A+Mar+10/26139925.html Tue, 10 Mar 2026 16:30:00 -0400 CANF CANF O.05892622 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Can-Fite+BioPharma+Ltd.+++For%3A+Mar+10/26139925.html si-local-file:///var/storage/secattach/20260310/26139925.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Can-Fite+BioPharma+Ltd.+++For%3A+Mar+10/26139925.html Tue, 10 Mar 2026 16:30:00 -0400 CANF CANF O.05892622 http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Can-Fite+BioPharma+Ltd.++++++++++++++/26115159.html si-local-file:///var/storage/secattach/20260305/26115159.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Can-Fite+BioPharma+Ltd.++++++++++++++/26115159.html Thu, 05 Mar 2026 07:32:00 -0400 CANF CANF O.05892622 http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Can-Fite+BioPharma+Ltd.++++++++++++++/26115159.html si-local-file:///var/storage/secattach/20260305/26115159.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Can-Fite+BioPharma+Ltd.++++++++++++++/26115159.html Thu, 05 Mar 2026 07:32:00 -0400 CANF CANF O.05892622 http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Can-Fite+BioPharma+Ltd.++++++++++++++/26115159.html si-local-file:///var/storage/secattach/20260305/26115159.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Can-Fite+BioPharma+Ltd.++++++++++++++/26115159.html Thu, 05 Mar 2026 07:32:00 -0400 CANF CANF O.05892622 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Can-Fite+BioPharma+Ltd.+++For%3A+Mar+05/26115101.html si-local-file:///var/storage/secattach/20260305/26115101.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Can-Fite+BioPharma+Ltd.+++For%3A+Mar+05/26115101.html Thu, 05 Mar 2026 07:29:00 -0400 CANF CANF O.05892622 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Can-Fite+BioPharma+Ltd.+++For%3A+Mar+05/26115101.html si-local-file:///var/storage/secattach/20260305/26115101.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Can-Fite+BioPharma+Ltd.+++For%3A+Mar+05/26115101.html Thu, 05 Mar 2026 07:29:00 -0400 CANF CANF O.05892622 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Can-Fite+BioPharma+Ltd.+++For%3A+Mar+05/26115101.html si-local-file:///var/storage/secattach/20260305/26115101.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Can-Fite+BioPharma+Ltd.+++For%3A+Mar+05/26115101.html Thu, 05 Mar 2026 07:29:00 -0400 CANF CANF O.05892622 http://www.streetinsider.com/Equity+Offerings/Can-Fite+raises+%244+million+through+warrant+exercise+agreement/26108694.html <p>Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) announced it entered into an agreement for the immediate exercise of warrants to purchase 795,869 American Depositary Shares at a reduced exercise price of $5.00 per ADS, down from the original $9.34 exercise price.</p><p>The biotechnology company expects to receive approximately $4.0 million in gross proceeds from the warrant exercise, with closing anticipated on March 5, 2026, subject to customary closing conditions. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering.</p><p>Under the agreement, Can-Fite will issue new unregistered warrants to purchase up to 1,591,738 ADSs with an exercise http://www.streetinsider.com/Equity+Offerings/Can-Fite+raises+%244+million+through+warrant+exercise+agreement/26108694.html Wed, 04 Mar 2026 10:26:19 -0400 CANF CFBI http://www.streetinsider.com/Equity+Offerings/Can-Fite+raises+%244+million+through+warrant+exercise+agreement/26108694.html <p>Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) announced it entered into an agreement for the immediate exercise of warrants to purchase 795,869 American Depositary Shares at a reduced exercise price of $5.00 per ADS, down from the original $9.34 exercise price.</p><p>The biotechnology company expects to receive approximately $4.0 million in gross proceeds from the warrant exercise, with closing anticipated on March 5, 2026, subject to customary closing conditions. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering.</p><p>Under the agreement, Can-Fite will issue new unregistered warrants to purchase up to 1,591,738 ADSs with an exercise http://www.streetinsider.com/Equity+Offerings/Can-Fite+raises+%244+million+through+warrant+exercise+agreement/26108694.html Wed, 04 Mar 2026 10:26:19 -0400 CANF CFBI http://www.streetinsider.com/Corporate+News/Can-Fite+raises+%244+million+through+warrant+exercise+agreement/26108694.html <p>Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) announced it entered into an agreement for the immediate exercise of warrants to purchase 795,869 American Depositary Shares at a reduced exercise price of $5.00 per ADS, down from the original $9.34 exercise price.</p><p>The biotechnology company expects to receive approximately $4.0 million in gross proceeds from the warrant exercise, with closing anticipated on March 5, 2026, subject to customary closing conditions. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering.</p><p>Under the agreement, Can-Fite will issue new unregistered warrants to purchase up to 1,591,738 ADSs with an exercise http://www.streetinsider.com/Corporate+News/Can-Fite+raises+%244+million+through+warrant+exercise+agreement/26108694.html Wed, 04 Mar 2026 10:26:19 -0400 CANF CFBI http://www.streetinsider.com/Corporate+News/Can-Fite+raises+%244+million+through+warrant+exercise+agreement/26108694.html <p>Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) announced it entered into an agreement for the immediate exercise of warrants to purchase 795,869 American Depositary Shares at a reduced exercise price of $5.00 per ADS, down from the original $9.34 exercise price.</p><p>The biotechnology company expects to receive approximately $4.0 million in gross proceeds from the warrant exercise, with closing anticipated on March 5, 2026, subject to customary closing conditions. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering.</p><p>Under the agreement, Can-Fite will issue new unregistered warrants to purchase up to 1,591,738 ADSs with an exercise http://www.streetinsider.com/Corporate+News/Can-Fite+raises+%244+million+through+warrant+exercise+agreement/26108694.html Wed, 04 Mar 2026 10:26:19 -0400 CANF CFBI http://www.streetinsider.com/Press+Releases/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html <p>RAMAT GAN, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 795,869 American Depositary Shares (ADSs), having an exercise price of $9.34 per ADS, issued by Can-Fite in July 2025, at a reduced exercise price of $5.00 per ADS. The ADSs representing ordinary shares issuable upon exercise of the http://www.streetinsider.com/Press+Releases/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html Wed, 04 Mar 2026 10:25:00 -0400 A.06822034 CANF CANF CFBI O.05892622 O.20026344 http://www.streetinsider.com/Press+Releases/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html <p>RAMAT GAN, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 795,869 American Depositary Shares (ADSs), having an exercise price of $9.34 per ADS, issued by Can-Fite in July 2025, at a reduced exercise price of $5.00 per ADS. The ADSs representing ordinary shares issuable upon exercise of the http://www.streetinsider.com/Press+Releases/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html Wed, 04 Mar 2026 10:25:00 -0400 A.06822034 CANF CANF CFBI O.05892622 O.20026344 http://www.streetinsider.com/Press+Releases/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html <p>RAMAT GAN, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 795,869 American Depositary Shares (ADSs), having an exercise price of $9.34 per ADS, issued by Can-Fite in July 2025, at a reduced exercise price of $5.00 per ADS. The ADSs representing ordinary shares issuable upon exercise of the http://www.streetinsider.com/Press+Releases/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html Wed, 04 Mar 2026 10:25:00 -0400 A.06822034 CANF CANF CFBI O.05892622 O.20026344 http://www.streetinsider.com/Press+Releases/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html <p>RAMAT GAN, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 795,869 American Depositary Shares (ADSs), having an exercise price of $9.34 per ADS, issued by Can-Fite in July 2025, at a reduced exercise price of $5.00 per ADS. The ADSs representing ordinary shares issuable upon exercise of the http://www.streetinsider.com/Press+Releases/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html Wed, 04 Mar 2026 10:25:00 -0400 A.06822034 CANF CANF CFBI O.05892622 O.20026344 http://www.streetinsider.com/Press+Releases/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html <p>RAMAT GAN, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 795,869 American Depositary Shares (ADSs), having an exercise price of $9.34 per ADS, issued by Can-Fite in July 2025, at a reduced exercise price of $5.00 per ADS. The ADSs representing ordinary shares issuable upon exercise of the http://www.streetinsider.com/Press+Releases/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html Wed, 04 Mar 2026 10:25:00 -0400 A.06822034 CANF CANF CFBI O.05892622 O.20026344 http://www.streetinsider.com/Press+Releases/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html <p>RAMAT GAN, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 795,869 American Depositary Shares (ADSs), having an exercise price of $9.34 per ADS, issued by Can-Fite in July 2025, at a reduced exercise price of $5.00 per ADS. The ADSs representing ordinary shares issuable upon exercise of the http://www.streetinsider.com/Press+Releases/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html Wed, 04 Mar 2026 10:25:00 -0400 A.06822034 CANF CANF CFBI O.05892622 O.20026344 http://www.streetinsider.com/Globe+Newswire/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html <p>RAMAT GAN, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 795,869 American Depositary Shares (ADSs), having an exercise price of $9.34 per ADS, issued by Can-Fite in July 2025, at a reduced exercise price of $5.00 per ADS. The ADSs representing ordinary shares issuable upon exercise of the http://www.streetinsider.com/Globe+Newswire/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html Wed, 04 Mar 2026 10:25:00 -0400 A.06822034 CANF CANF CFBI O.05892622 O.20026344 http://www.streetinsider.com/Globe+Newswire/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html <p>RAMAT GAN, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 795,869 American Depositary Shares (ADSs), having an exercise price of $9.34 per ADS, issued by Can-Fite in July 2025, at a reduced exercise price of $5.00 per ADS. The ADSs representing ordinary shares issuable upon exercise of the http://www.streetinsider.com/Globe+Newswire/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html Wed, 04 Mar 2026 10:25:00 -0400 A.06822034 CANF CANF CFBI O.05892622 O.20026344 http://www.streetinsider.com/Globe+Newswire/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html <p>RAMAT GAN, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 795,869 American Depositary Shares (ADSs), having an exercise price of $9.34 per ADS, issued by Can-Fite in July 2025, at a reduced exercise price of $5.00 per ADS. The ADSs representing ordinary shares issuable upon exercise of the http://www.streetinsider.com/Globe+Newswire/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html Wed, 04 Mar 2026 10:25:00 -0400 A.06822034 CANF CANF CFBI O.05892622 O.20026344 http://www.streetinsider.com/Globe+Newswire/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html <p>RAMAT GAN, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 795,869 American Depositary Shares (ADSs), having an exercise price of $9.34 per ADS, issued by Can-Fite in July 2025, at a reduced exercise price of $5.00 per ADS. The ADSs representing ordinary shares issuable upon exercise of the http://www.streetinsider.com/Globe+Newswire/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html Wed, 04 Mar 2026 10:25:00 -0400 A.06822034 CANF CANF CFBI O.05892622 O.20026344 http://www.streetinsider.com/Globe+Newswire/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html <p>RAMAT GAN, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 795,869 American Depositary Shares (ADSs), having an exercise price of $9.34 per ADS, issued by Can-Fite in July 2025, at a reduced exercise price of $5.00 per ADS. The ADSs representing ordinary shares issuable upon exercise of the http://www.streetinsider.com/Globe+Newswire/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html Wed, 04 Mar 2026 10:25:00 -0400 A.06822034 CANF CANF CFBI O.05892622 O.20026344 http://www.streetinsider.com/Globe+Newswire/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html <p>RAMAT GAN, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 795,869 American Depositary Shares (ADSs), having an exercise price of $9.34 per ADS, issued by Can-Fite in July 2025, at a reduced exercise price of $5.00 per ADS. The ADSs representing ordinary shares issuable upon exercise of the http://www.streetinsider.com/Globe+Newswire/Can-Fite+Announces+Exercise+of+Warrants+for+Approximately+%244.0+Million+in+Gross+Proceeds/26108689.html Wed, 04 Mar 2026 10:25:00 -0400 A.06822034 CANF CANF CFBI O.05892622 O.20026344